HilleVax, Inc.

The momentum for this stock is not very good. HilleVax, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in HilleVax, Inc..

News

Brokerages Set HilleVax, Inc. (NASDAQ:HLVX) Target Price at $9.20

Ticker Report Shares of HilleVax, Inc. (NASDAQ:HLVX - Get Free Report) have been given a consensus rating of "Hold" by the six brokerages that are currently covering the company, Marketbeat reports. Six equities...\n more…

Reviewing HilleVax (NASDAQ:HLVX) & Cyclo Therapeutics (NASDAQ:CYTH)

Zolmax HilleVax (NASDAQ:HLVX - Get Free Report) and Cyclo Therapeutics (NASDAQ:CYTH - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two...\n more…

Q3 2024 Earnings Forecast for HilleVax, Inc. (NASDAQ:HLVX) Issued By HC Wainwright

Zolmax HilleVax, Inc. (NASDAQ:HLVX - Free Report) - Investment analysts at HC Wainwright lifted their Q3 2024 earnings per share (EPS) estimates for shares of HilleVax in a research report issued to...\n more…

HilleVax, Inc.: Prudent Cost Management Amidst Trial Setbacks Hold Rating Justified

TipRanks Financial Blog Earnings Calendar Dividend Calendar Economic Calendar IPO Calendar Stock Splits Stock Buybacks Market Holidays\n more…

HilleVax (NASDAQ:HLVX) Receives Neutral Rating from HC Wainwright

Ticker Report HC Wainwright restated their neutral rating on shares of HilleVax (NASDAQ:HLVX - Free Report) in a research note published on Monday, Benzinga reports. They currently have a $2.00 price objective on...\n more…

Vanguard Group Inc. Has $22.66 Million Holdings in HilleVax, Inc. (NASDAQ:HLVX)

Ticker Report Vanguard Group Inc. lessened its holdings in shares of HilleVax, Inc. (NASDAQ:HLVX - Free Report) by 7.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned...\n more…